Targeting the chromatin structural changes of antitumor immunity

Area of Science:

• Oncology
• Immunology
• Epigenetics

Background:

• Epigenomic alterations are hallmarks of cancer, driving abnormal gene expression.
• These changes impact not only cancer development but also tumor immunogenicity and anti-tumor immunity.
• Understanding these links is crucial for novel therapeutic strategies.

Purpose of the Study:

• To explore the intricate relationship between epigenetic regulation and tumor immune cell function.
• To highlight the role of DNA methylation, histone modifications, and chromatin structure in tumor immunogenicity.
• To discuss the therapeutic potential of targeting epigenetic processes in cancer immunotherapy.

Main Methods:

• Review of key epigenetic mechanisms: DNA methylation, histone post-translational modification, and chromatin remodeling.
• Analysis of how these epigenetic changes influence tumor immunogenicity and immune cell activity.
• Examination of epigenetic research methodologies.

Main Results:

• Epigenetic dysregulation significantly impacts tumor immunogenicity and the tumor microenvironment.
• Abnormal epigenetic processes like DNA methylation and histone modifications alter immune cell function.
• Small-molecule inhibitors targeting epigenetic modulators show promise in boosting anti-tumor immunity.

Conclusions:

• Epigenetic therapy holds significant potential for enhancing cancer immunotherapy efficacy.
• Combining epigenetic modulators with immunotherapy requires careful consideration of complex interactions.
• Further research is needed to optimize combination treatment plans for improved patient outcomes.